As of Sep 18
| +0.04 / +1.08%|
The 7 analysts offering 12-month price forecasts for Achillion Pharmaceuticals Inc have a median target of 8.00, with a high estimate of 13.00 and a low estimate of 4.00. The median estimate represents a +113.90% increase from the last price of 3.74.
The current consensus among 7 polled investment analysts is to Buy stock in Achillion Pharmaceuticals Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.